A treatment for narcolepsy could help people give up smoking, according to a
patent filed by pharmaceuticals giant Glaxo Wellcome (WO 99/25355). Glaxo鈥檚
researchers have found that a compound developed for the treatment of
narcolepsy-cataplexy syndrome and depression has the surprising effect of
countering addiction to nicotine. The compound, containing complex fluorophenyl
groups, can either be administered by mouth or injected. Glaxo admits it is not
yet sure how the drug works, but believes it affects one particular group of
neurotransmitters.
More from New Scientist
Explore the latest news, articles and features
Technology
Test moderators use AI-generated writing to judge literacy standards
News
Mind
THC in cannabis may reduce nightmares in people with PTSD
News
Environment
Fishers detonate a bomb every hour on one Indonesian coral reef
News
Environment
How bad is the UK drought and how long will it continue?
News
Popular articles
Trending New Scientist articles